Vanguard's Stake in Spire Healthcare Revealed Through Form 8.3

The Vanguard Group, Inc. disclosed its position in Spire Healthcare Group PLC via Form 8.3, filed under the UK Takeover Code. As of October 15, 2025, Vanguard reported holding 14,375,956 ordinary shares, representing 3.57% of Spire's total shares. This disclosure underlines Vanguard's significant interest, exceeding the 1% threshold mandated for public disclosure under Rule 8.3 of the Code.

Vanguard's filing also includes recent transactions. Notably, a purchase of 2,344 ordinary shares at a rate of 2.42 GBP each was made, illustrating ongoing investment activities. The form indicates no current derivative positions or new securities rights linked to Spire.

The disclosure confirms no agreements or arrangements regarding securities voting rights or acquisitions. This clarity helps stakeholders understand Vanguard’s specific interests and position in Spire Healthcare.